Champions Oncology CSBR
NASDAQ CSBR
$5.18 +0.24 (+4.86%)
At close: Aug 20, 2026 · 4:00 PM EDT

Champions Oncology (CSBR) Goodwill (2011 - 2026)

Champions Oncology (CSBR) posted quarterly Goodwill of $335000.0 for Q2 2026, little changed year-over-year from $335000.0 in Q2 2025, and little changed quarter-over-quarter from $335000.0 in Q1 2026.

Champions Oncology (CSBR) Goodwill (2011 - 2026) Analysis & Trends

Champions Oncology's Goodwill history runs 16 years deep, the most recent figure standing at $335000.0 for Q2 2026.

  • In Q2 2026, Goodwill changed 0.0% year-over-year to $335000.0; the TTM figure through Apr 2026 stood at $335000.0 (changed 0.0% YoY), while the FY2026 annual figure was $335000.0, changed 0.0% from the prior year.
  • Goodwill for Q2 2026 stood at $335000.0, roughly flat from $335000.0 in the prior quarter.
  • The five-year high for Goodwill was $335000.0 in Q1 2022, with the low at $335000.0 in Q1 2022.
  • The 5-year median for Goodwill is $335000.0 (2022), against an average of $335000.0.
  • Peak annual rise in Goodwill reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
  • Champions Oncology's Goodwill stood at $335000.0 in 2022, then changed by 0.0% to $335000.0 in 2023, then changed by 0.0% to $335000.0 in 2024, then changed by 0.0% to $335000.0 in 2025, then changed by 0.0% to $335000.0 in 2026.
  • Business Quant data shows CSBR's Goodwill at $335000.0 in Q2 2026, $335000.0 in Q1 2026, and $335000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Champions Oncology 71.17 Mn 71.17 Mn 7.03 Mn

Historic Data

Download Data
DateValue
Apr 30, 2026 335,000.00
Jan 31, 2026 335,000.00
Oct 31, 2025 335,000.00
Jul 31, 2025 335,000.00
Apr 30, 2025 335,000.00
Jan 31, 2025 335,000.00
Oct 31, 2024 335,000.00
Jul 31, 2024 335,000.00
Apr 30, 2024 335,000.00
Jan 31, 2024 335,000.00
Oct 31, 2023 335,000.00
Jul 31, 2023 335,000.00
Apr 30, 2023 335,000.00
Jan 31, 2023 335,000.00
Oct 31, 2022 335,000.00
Jul 31, 2022 335,000.00
Apr 30, 2022 335,000.00
Jan 31, 2022 335,000.00
Oct 31, 2021 335,000.00
Jul 31, 2021 335,000.00